調査レポート | • レポートコード：QYR2104Z3895 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、分子式インフルエンザ診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（逆転写ポリメラーゼ連鎖反応（RT-PCR）、核酸配列増幅（NASBA）検査、ループ媒介等温増幅アッセイ（LAMP）、単純増幅アッセイ（SAMBA））、用途別市場規模（病院、POCT、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・分子式インフルエンザ診断の市場動向 ・企業の競争状況、市場シェア ・分子式インフルエンザ診断の種類別市場規模（逆転写ポリメラーゼ連鎖反応（RT-PCR）、核酸配列増幅（NASBA）検査、ループ媒介等温増幅アッセイ（LAMP）、単純増幅アッセイ（SAMBA）） ・分子式インフルエンザ診断の用途別市場規模（病院、POCT、その他） ・分子式インフルエンザ診断の北米市場規模2016-2027（アメリカ、カナダ） ・分子式インフルエンザ診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・分子式インフルエンザ診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・分子式インフルエンザ診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・分子式インフルエンザ診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BD、Abbott (Include Alere)、Roche、SIEMENS、Analytik Jena、Quidel、Thermo Fisher、Meridian Bioscience、BioMerieux、Sekisui Diagnostics、Response Biomedical、SA Scientific） ・結論 |
Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.
Market Analysis and Insights: Global Molecular Influenza Diagnostic Market
The global Molecular Influenza Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Influenza Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Influenza Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Influenza Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Influenza Diagnostic market.
Global Molecular Influenza Diagnostic Scope and Market Size
Molecular Influenza Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Influenza Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Nucleic Acid Sequence Based Amplification (NASBA) Tests
Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-based Assays (SAMBA)
Segment by Application
Hospitals
POCT
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
1.2.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests
1.2.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
1.2.5 Simple Amplification-based Assays (SAMBA)
1.3 Market by Application
1.3.1 Global Molecular Influenza Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Influenza Diagnostic Market Perspective (2016-2027)
2.2 Molecular Influenza Diagnostic Growth Trends by Regions
2.2.1 Molecular Influenza Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Influenza Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Influenza Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Influenza Diagnostic Industry Dynamic
2.3.1 Molecular Influenza Diagnostic Market Trends
2.3.2 Molecular Influenza Diagnostic Market Drivers
2.3.3 Molecular Influenza Diagnostic Market Challenges
2.3.4 Molecular Influenza Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Influenza Diagnostic Players by Revenue
3.1.1 Global Top Molecular Influenza Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Influenza Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Influenza Diagnostic Revenue
3.4 Global Molecular Influenza Diagnostic Market Concentration Ratio
3.4.1 Global Molecular Influenza Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Influenza Diagnostic Revenue in 2020
3.5 Molecular Influenza Diagnostic Key Players Head office and Area Served
3.6 Key Players Molecular Influenza Diagnostic Product Solution and Service
3.7 Date of Enter into Molecular Influenza Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Influenza Diagnostic Breakdown Data by Type
4.1 Global Molecular Influenza Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2022-2027)
5 Molecular Influenza Diagnostic Breakdown Data by Application
5.1 Global Molecular Influenza Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Influenza Diagnostic Market Size (2016-2027)
6.2 North America Molecular Influenza Diagnostic Market Size by Type
6.2.1 North America Molecular Influenza Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Molecular Influenza Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Molecular Influenza Diagnostic Market Size by Type (2016-2027)
6.3 North America Molecular Influenza Diagnostic Market Size by Application
6.3.1 North America Molecular Influenza Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Molecular Influenza Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Molecular Influenza Diagnostic Market Size by Application (2016-2027)
6.4 North America Molecular Influenza Diagnostic Market Size by Country
6.4.1 North America Molecular Influenza Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Molecular Influenza Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Molecular Influenza Diagnostic Market Size (2016-2027)
7.2 Europe Molecular Influenza Diagnostic Market Size by Type
7.2.1 Europe Molecular Influenza Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Molecular Influenza Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Molecular Influenza Diagnostic Market Size by Type (2016-2027)
7.3 Europe Molecular Influenza Diagnostic Market Size by Application
7.3.1 Europe Molecular Influenza Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Molecular Influenza Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Molecular Influenza Diagnostic Market Size by Application (2016-2027)
7.4 Europe Molecular Influenza Diagnostic Market Size by Country
7.4.1 Europe Molecular Influenza Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Molecular Influenza Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Influenza Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type
8.2.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application
8.3.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region
8.4.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Influenza Diagnostic Market Size (2016-2027)
9.2 Latin America Molecular Influenza Diagnostic Market Size by Type
9.2.1 Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Influenza Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Molecular Influenza Diagnostic Market Size by Application
9.3.1 Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Influenza Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Molecular Influenza Diagnostic Market Size by Country
9.4.1 Latin America Molecular Influenza Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Influenza Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Influenza Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type
10.2.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application
10.3.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country
10.4.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Molecular Influenza Diagnostic Introduction
11.1.4 BD Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.1.5 BD Recent Development
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Details
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Introduction
11.2.4 Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.2.5 Abbott (Include Alere) Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Molecular Influenza Diagnostic Introduction
11.3.4 Roche Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.3.5 Roche Recent Development
11.4 SIEMENS
11.4.1 SIEMENS Company Details
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Molecular Influenza Diagnostic Introduction
11.4.4 SIEMENS Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.4.5 SIEMENS Recent Development
11.5 Analytik Jena
11.5.1 Analytik Jena Company Details
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Molecular Influenza Diagnostic Introduction
11.5.4 Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.5.5 Analytik Jena Recent Development
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Molecular Influenza Diagnostic Introduction
11.6.4 Quidel Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.6.5 Quidel Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Molecular Influenza Diagnostic Introduction
11.7.4 Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.7.5 Thermo Fisher Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Molecular Influenza Diagnostic Introduction
11.8.4 Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.8.5 Meridian Bioscience Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Molecular Influenza Diagnostic Introduction
11.9.4 BioMerieux Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Introduction
11.10.4 Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Molecular Influenza Diagnostic Introduction
11.11.4 Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
11.12.1 SA Scientific Company Details
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Molecular Influenza Diagnostic Introduction
11.12.4 SA Scientific Revenue in Molecular Influenza Diagnostic Business (2016-2021)
11.12.5 SA Scientific Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Molecular Influenza Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Table 3. Key Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests
Table 4. Key Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Table 5. Key Players of Simple Amplification-based Assays (SAMBA)
Table 6. Global Molecular Influenza Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Molecular Influenza Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Molecular Influenza Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Molecular Influenza Diagnostic Market Share by Regions (2016-2021)
Table 10. Global Molecular Influenza Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Molecular Influenza Diagnostic Market Share by Regions (2022-2027)
Table 12. Molecular Influenza Diagnostic Market Trends
Table 13. Molecular Influenza Diagnostic Market Drivers
Table 14. Molecular Influenza Diagnostic Market Challenges
Table 15. Molecular Influenza Diagnostic Market Restraints
Table 16. Global Molecular Influenza Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Molecular Influenza Diagnostic Market Share by Players (2016-2021)
Table 18. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Diagnostic as of 2020)
Table 19. Ranking of Global Top Molecular Influenza Diagnostic Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Molecular Influenza Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Influenza Diagnostic Product Solution and Service
Table 23. Date of Enter into Molecular Influenza Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2016-2021)
Table 27. Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Molecular Influenza Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Molecular Influenza Diagnostic Revenue Market Share by Application (2016-2021)
Table 31. Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Molecular Influenza Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 63. BD Company Details
Table 64. BD Business Overview
Table 65. BD Molecular Influenza Diagnostic Product
Table 66. BD Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 67. BD Recent Development
Table 68. Abbott (Include Alere) Company Details
Table 69. Abbott (Include Alere) Business Overview
Table 70. Abbott (Include Alere) Molecular Influenza Diagnostic Product
Table 71. Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 72. Abbott (Include Alere) Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Molecular Influenza Diagnostic Product
Table 76. Roche Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. SIEMENS Company Details
Table 79. SIEMENS Business Overview
Table 80. SIEMENS Molecular Influenza Diagnostic Product
Table 81. SIEMENS Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 82. SIEMENS Recent Development
Table 83. Analytik Jena Company Details
Table 84. Analytik Jena Business Overview
Table 85. Analytik Jena Molecular Influenza Diagnostic Product
Table 86. Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 87. Analytik Jena Recent Development
Table 88. Quidel Company Details
Table 89. Quidel Business Overview
Table 90. Quidel Molecular Influenza Diagnostic Product
Table 91. Quidel Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 92. Quidel Recent Development
Table 93. Thermo Fisher Company Details
Table 94. Thermo Fisher Business Overview
Table 95. Thermo Fisher Molecular Influenza Diagnostic Product
Table 96. Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 97. Thermo Fisher Recent Development
Table 98. Meridian Bioscience Company Details
Table 99. Meridian Bioscience Business Overview
Table 100. Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 101. Meridian Bioscience Recent Development
Table 102. BioMerieux Company Details
Table 103. BioMerieux Business Overview
Table 104. BioMerieux Molecular Influenza Diagnostic Product
Table 105. BioMerieux Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 106. BioMerieux Recent Development
Table 107. Sekisui Diagnostics Company Details
Table 108. Sekisui Diagnostics Business Overview
Table 109. Sekisui Diagnostics Molecular Influenza Diagnostic Product
Table 110. Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 111. Sekisui Diagnostics Recent Development
Table 112. Response Biomedical Company Details
Table 113. Response Biomedical Business Overview
Table 114. Response Biomedical Molecular Influenza Diagnostic Product
Table 115. Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 116. Response Biomedical Recent Development
Table 117. SA Scientific Company Details
Table 118. SA Scientific Business Overview
Table 119. SA Scientific Molecular Influenza Diagnostic Product
Table 120. SA Scientific Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)
Table 121. SA Scientific Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Influenza Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) Features
Figure 3. Nucleic Acid Sequence Based Amplification (NASBA) Tests Features
Figure 4. Loop-mediated Isothermal Amplification-Based Assays (LAMP) Features
Figure 5. Simple Amplification-based Assays (SAMBA) Features
Figure 6. Global Molecular Influenza Diagnostic Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. POCT Case Studies
Figure 9. Others Case Studies
Figure 10. Molecular Influenza Diagnostic Report Years Considered
Figure 11. Global Molecular Influenza Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Molecular Influenza Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Molecular Influenza Diagnostic Market Share by Regions: 2020 VS 2027
Figure 14. Global Molecular Influenza Diagnostic Market Share by Regions (2022-2027)
Figure 15. Global Molecular Influenza Diagnostic Market Share by Players in 2020
Figure 16. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Diagnostic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Molecular Influenza Diagnostic Revenue in 2020
Figure 18. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2016-2021)
Figure 19. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2022-2027)
Figure 20. North America Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Molecular Influenza Diagnostic Market Share by Type (2016-2027)
Figure 22. North America Molecular Influenza Diagnostic Market Share by Application (2016-2027)
Figure 23. North America Molecular Influenza Diagnostic Market Share by Country (2016-2027)
Figure 24. United States Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Molecular Influenza Diagnostic Market Share by Type (2016-2027)
Figure 28. Europe Molecular Influenza Diagnostic Market Share by Application (2016-2027)
Figure 29. Europe Molecular Influenza Diagnostic Market Share by Country (2016-2027)
Figure 30. Germany Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Molecular Influenza Diagnostic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Molecular Influenza Diagnostic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Molecular Influenza Diagnostic Market Share by Region (2016-2027)
Figure 40. China Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Molecular Influenza Diagnostic Market Share by Type (2016-2027)
Figure 48. Latin America Molecular Influenza Diagnostic Market Share by Application (2016-2027)
Figure 49. Latin America Molecular Influenza Diagnostic Market Share by Country (2016-2027)
Figure 50. Mexico Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Molecular Influenza Diagnostic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Molecular Influenza Diagnostic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Molecular Influenza Diagnostic Market Share by Country (2016-2027)
Figure 56. Turkey Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. BD Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 60. Abbott (Include Alere) Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 62. SIEMENS Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 63. Analytik Jena Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 64. Quidel Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 65. Thermo Fisher Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 66. Meridian Bioscience Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 67. BioMerieux Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 68. Sekisui Diagnostics Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 69. Response Biomedical Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 70. SA Scientific Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の呼吸器疾患用LAMP（ループ介在等温増幅）技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market The global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 20…- 世界の呼吸器疾患用LAMP（ループ介在等温増幅）技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market The global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 20…
- 世界の等温核酸増幅技術（INAAT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indu…
- 世界の核酸ベース診断市場規模・現状・予測（2021年-2027年） Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcript…
- 世界の核酸増幅検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nucleic Acid Amplification Testing Market The global Nucleic Acid Amplification Testing market size is projected to reach US$ 177.3 million by 2026, from US$ 131.5 million in 2019, at a CAGR of 4.3% during 2021-2026. With industry-standard accuracy in analysis an…